[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Vaccine Adjuvants Market Professional Survey Report 2018

July 2018 | 112 pages | ID: G7D385E8177EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Vaccine Adjuvants market status and forecast, categorizes the global Vaccine Adjuvants market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.

The global Vaccine Adjuvants market is valued at 560 million US$ in 2017 and will reach 1220 million US$ by the end of 2025, growing at a CAGR of 10.2% during 2018-2025.

The major manufacturers covered in this report
  • SEPPIC
  • SDA BIO
  • Brenntag Biosector
  • SPI Pharma
  • MVP Laboratories
  • Tj Kaiwei
  • Novavax
  • Zhuoyue
  • Aphios
  • GSK
  • CSL Limited
  • Brenntag Biosector
  • SEPPIC
  • SPI Pharma
  • Novavax
  • Avanti Polar Lipids
  • Aphios
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
  • North America
  • Europe
  • China
  • Japan
  • India
  • Southeast Asia
  • Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Oral
  • Subcutaneous
  • Intramuscular
  • Others
By Application, the market can be split into
  • Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
  • Human Vaccine Adjuvants (Research Applications, Commercial Applications)
The study objectives of this report are:
  • To analyze and study the global Vaccine Adjuvants capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
  • Focuses on the key Vaccine Adjuvants manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Vaccine Adjuvants are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Vaccine Adjuvants Manufacturers
Vaccine Adjuvants Distributors/Traders/Wholesalers
Vaccine Adjuvants Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
  • With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
  • Regional and country-level analysis of the Vaccine Adjuvants market, by end-use.
  • Detailed analysis and profiles of additional market players.
Global Vaccine Adjuvants Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF VACCINE ADJUVANTS

1.1 Definition and Specifications of Vaccine Adjuvants
  1.1.1 Definition of Vaccine Adjuvants
  1.1.2 Specifications of Vaccine Adjuvants
1.2 Classification of Vaccine Adjuvants
  1.2.1 Oral
  1.2.2 Subcutaneous
  1.2.3 Intramuscular
  1.2.4 Others
1.3 Applications of Vaccine Adjuvants
  1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
  1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF VACCINE ADJUVANTS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Vaccine Adjuvants
2.3 Manufacturing Process Analysis of Vaccine Adjuvants
2.4 Industry Chain Structure of Vaccine Adjuvants

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF VACCINE ADJUVANTS

3.1 Capacity and Commercial Production Date of Global Vaccine Adjuvants Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Vaccine Adjuvants Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Vaccine Adjuvants Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Vaccine Adjuvants Major Manufacturers in 2017

4 GLOBAL VACCINE ADJUVANTS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Vaccine Adjuvants Capacity and Growth Rate Analysis
  4.2.2 2017 Vaccine Adjuvants Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Vaccine Adjuvants Sales and Growth Rate Analysis
  4.3.2 2017 Vaccine Adjuvants Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Vaccine Adjuvants Sales Price
  4.4.2 2017 Vaccine Adjuvants Sales Price Analysis (Company Segment)

5 VACCINE ADJUVANTS REGIONAL MARKET ANALYSIS

5.1 North America Vaccine Adjuvants Market Analysis
  5.1.1 North America Vaccine Adjuvants Market Overview
  5.1.2 North America 2013-2018E Vaccine Adjuvants Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Vaccine Adjuvants Sales Price Analysis
  5.1.4 North America 2017 Vaccine Adjuvants Market Share Analysis
5.2 Europe Vaccine Adjuvants Market Analysis
  5.2.1 Europe Vaccine Adjuvants Market Overview
  5.2.2 Europe 2013-2018E Vaccine Adjuvants Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Vaccine Adjuvants Sales Price Analysis
  5.2.4 Europe 2017 Vaccine Adjuvants Market Share Analysis
5.3 China Vaccine Adjuvants Market Analysis
  5.3.1 China Vaccine Adjuvants Market Overview
  5.3.2 China 2013-2018E Vaccine Adjuvants Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Vaccine Adjuvants Sales Price Analysis
  5.3.4 China 2017 Vaccine Adjuvants Market Share Analysis
5.4 Japan Vaccine Adjuvants Market Analysis
  5.4.1 Japan Vaccine Adjuvants Market Overview
  5.4.2 Japan 2013-2018E Vaccine Adjuvants Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Vaccine Adjuvants Sales Price Analysis
  5.4.4 Japan 2017 Vaccine Adjuvants Market Share Analysis
5.5 Southeast Asia Vaccine Adjuvants Market Analysis
  5.5.1 Southeast Asia Vaccine Adjuvants Market Overview
  5.5.2 Southeast Asia 2013-2018E Vaccine Adjuvants Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Vaccine Adjuvants Sales Price Analysis
  5.5.4 Southeast Asia 2017 Vaccine Adjuvants Market Share Analysis
5.6 India Vaccine Adjuvants Market Analysis
  5.6.1 India Vaccine Adjuvants Market Overview
  5.6.2 India 2013-2018E Vaccine Adjuvants Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Vaccine Adjuvants Sales Price Analysis
  5.6.4 India 2017 Vaccine Adjuvants Market Share Analysis

6 GLOBAL 2013-2018E VACCINE ADJUVANTS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Vaccine Adjuvants Sales by Type
6.2 Different Types of Vaccine Adjuvants Product Interview Price Analysis
6.3 Different Types of Vaccine Adjuvants Product Driving Factors Analysis
  6.3.1 Oral Growth Driving Factor Analysis
  6.3.2 Subcutaneous Growth Driving Factor Analysis
  6.3.3 Intramuscular Growth Driving Factor Analysis
  6.3.4 Others Growth Driving Factor Analysis

7 GLOBAL 2013-2018E VACCINE ADJUVANTS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Vaccine Adjuvants Consumption by Application
7.2 Different Application of Vaccine Adjuvants Product Interview Price Analysis
7.3 Different Application of Vaccine Adjuvants Product Driving Factors Analysis
  7.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) of Vaccine Adjuvants Growth Driving Factor Analysis
  7.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications) of Vaccine Adjuvants Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF VACCINE ADJUVANTS

8.1 SEPPIC
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 SEPPIC 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 SEPPIC 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.2 SDA BIO
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 SDA BIO 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 SDA BIO 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.3 Brenntag Biosector
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Brenntag Biosector 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Brenntag Biosector 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.4 SPI Pharma
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 SPI Pharma 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 SPI Pharma 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.5 MVP Laboratories
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 MVP Laboratories 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 MVP Laboratories 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.6 Tj Kaiwei
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Tj Kaiwei 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Tj Kaiwei 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.7 Novavax
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novavax 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novavax 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.8 Zhuoyue
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Zhuoyue 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Zhuoyue 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.9 Aphios
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Aphios 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Aphios 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.10 GSK
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 GSK 2017 Vaccine Adjuvants Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 GSK 2017 Vaccine Adjuvants Business Region Distribution Analysis
8.11 CSL Limited
8.12 Brenntag Biosector
8.13 SEPPIC
8.14 SPI Pharma
8.15 Novavax
8.16 Avanti Polar Lipids
8.17 Aphios

9 DEVELOPMENT TREND OF ANALYSIS OF VACCINE ADJUVANTS MARKET

9.1 Global Vaccine Adjuvants Market Trend Analysis
  9.1.1 Global 2018-2025 Vaccine Adjuvants Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Vaccine Adjuvants Sales Price Forecast
9.2 Vaccine Adjuvants Regional Market Trend
  9.2.1 North America 2018-2025 Vaccine Adjuvants Consumption Forecast
  9.2.2 Europe 2018-2025 Vaccine Adjuvants Consumption Forecast
  9.2.3 China 2018-2025 Vaccine Adjuvants Consumption Forecast
  9.2.4 Japan 2018-2025 Vaccine Adjuvants Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Vaccine Adjuvants Consumption Forecast
  9.2.6 India 2018-2025 Vaccine Adjuvants Consumption Forecast
9.3 Vaccine Adjuvants Market Trend (Product Type)
9.4 Vaccine Adjuvants Market Trend (Application)

10 VACCINE ADJUVANTS MARKETING TYPE ANALYSIS

10.1 Vaccine Adjuvants Regional Marketing Type Analysis
10.2 Vaccine Adjuvants International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Vaccine Adjuvants by Region
10.4 Vaccine Adjuvants Supply Chain Analysis

11 CONSUMERS ANALYSIS OF VACCINE ADJUVANTS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL VACCINE ADJUVANTS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Vaccine Adjuvants
Table Product Specifications of Vaccine Adjuvants
Table Classification of Vaccine Adjuvants
Figure Global Production Market Share of Vaccine Adjuvants by Type in 2017
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Subcutaneous Picture
Table Major Manufacturers of Subcutaneous
Figure Intramuscular Picture
Table Major Manufacturers of Intramuscular
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Vaccine Adjuvants
Figure Global Consumption Volume Market Share of Vaccine Adjuvants by Application in 2017
Figure Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Examples
Table Major Consumers in Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure Human Vaccine Adjuvants (Research Applications, Commercial Applications) Examples
Table Major Consumers in Human Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure Market Share of Vaccine Adjuvants by Regions
Figure North America Vaccine Adjuvants Market Size (Million USD) (2013-2025)
Figure Europe Vaccine Adjuvants Market Size (Million USD) (2013-2025)
Figure China Vaccine Adjuvants Market Size (Million USD) (2013-2025)
Figure Japan Vaccine Adjuvants Market Size (Million USD) (2013-2025)
Figure Southeast Asia Vaccine Adjuvants Market Size (Million USD) (2013-2025)
Figure India Vaccine Adjuvants Market Size (Million USD) (2013-2025)
Table Vaccine Adjuvants Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Vaccine Adjuvants in 2017
Figure Manufacturing Process Analysis of Vaccine Adjuvants
Figure Industry Chain Structure of Vaccine Adjuvants
Table Capacity and Commercial Production Date of Global Vaccine Adjuvants Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Vaccine Adjuvants Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Vaccine Adjuvants Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Vaccine Adjuvants Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Vaccine Adjuvants 2013-2018E
Figure Global 2013-2018E Vaccine Adjuvants Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Vaccine Adjuvants Market Size (Value) and Growth Rate
Table 2013-2018E Global Vaccine Adjuvants Capacity and Growth Rate
Table 2017 Global Vaccine Adjuvants Capacity (MT) List (Company Segment)
Table 2013-2018E Global Vaccine Adjuvants Sales (MT) and Growth Rate
Table 2017 Global Vaccine Adjuvants Sales (MT) List (Company Segment)
Table 2013-2018E Global Vaccine Adjuvants Sales Price (USD/Kg)
Table 2017 Global Vaccine Adjuvants Sales Price (USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Vaccine Adjuvants 2013-2018E
Figure North America 2013-2018E Vaccine Adjuvants Sales Price (USD/Kg)
Figure North America 2017 Vaccine Adjuvants Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Vaccine Adjuvants 2013-2018E
Figure Europe 2013-2018E Vaccine Adjuvants Sales Price (USD/Kg)
Figure Europe 2017 Vaccine Adjuvants Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Vaccine Adjuvants 2013-2018E
Figure China 2013-2018E Vaccine Adjuvants Sales Price (USD/Kg)
Figure China 2017 Vaccine Adjuvants Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Vaccine Adjuvants 2013-2018E
Figure Japan 2013-2018E Vaccine Adjuvants Sales Price (USD/Kg)
Figure Japan 2017 Vaccine Adjuvants Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Vaccine Adjuvants 2013-2018E
Figure Southeast Asia 2013-2018E Vaccine Adjuvants Sales Price (USD/Kg)
Figure Southeast Asia 2017 Vaccine Adjuvants Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Vaccine Adjuvants 2013-2018E
Figure India 2013-2018E Vaccine Adjuvants Sales Price (USD/Kg)
Figure India 2017 Vaccine Adjuvants Sales Market Share
Table Global 2013-2018E Vaccine Adjuvants Sales (MT) by Type
Table Different Types Vaccine Adjuvants Product Interview Price
Table Global 2013-2018E Vaccine Adjuvants Sales (MT) by Application
Table Different Application Vaccine Adjuvants Product Interview Price
Table SEPPIC Information List
Table Product Overview
Table 2017 SEPPIC Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 SEPPIC Vaccine Adjuvants Business Region Distribution
Table SDA BIO Information List
Table Product Overview
Table 2017 SDA BIO Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 SDA BIO Vaccine Adjuvants Business Region Distribution
Table Brenntag Biosector Information List
Table Product Overview
Table 2017 Brenntag Biosector Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Brenntag Biosector Vaccine Adjuvants Business Region Distribution
Table SPI Pharma Information List
Table Product Overview
Table 2017 SPI Pharma Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 SPI Pharma Vaccine Adjuvants Business Region Distribution
Table MVP Laboratories Information List
Table Product Overview
Table 2017 MVP Laboratories Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 MVP Laboratories Vaccine Adjuvants Business Region Distribution
Table Tj Kaiwei Information List
Table Product Overview
Table 2017 Tj Kaiwei Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Tj Kaiwei Vaccine Adjuvants Business Region Distribution
Table Novavax Information List
Table Product Overview
Table 2017 Novavax Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Novavax Vaccine Adjuvants Business Region Distribution
Table Zhuoyue Information List
Table Product Overview
Table 2017 Zhuoyue Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Zhuoyue Vaccine Adjuvants Business Region Distribution
Table Aphios Information List
Table Product Overview
Table 2017 Aphios Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 Aphios Vaccine Adjuvants Business Region Distribution
Table GSK Information List
Table Product Overview
Table 2017 GSK Vaccine Adjuvants Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2017 GSK Vaccine Adjuvants Business Region Distribution
Table CSL Limited Information List
Table Brenntag Biosector Information List
Table SEPPIC Information List
Table SPI Pharma Information List
Table Novavax Information List
Table Avanti Polar Lipids Information List
Table Aphios Information List
Figure Global 2018-2025 Vaccine Adjuvants Market Size (MT) and Growth Rate Forecast
Figure Global 2018-2025 Vaccine Adjuvants Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Vaccine Adjuvants Sales Price (USD/Kg) Forecast
Figure North America 2018-2025 Vaccine Adjuvants Consumption Volume (MT) and Growth Rate Forecast
Figure China 2018-2025 Vaccine Adjuvants Consumption Volume (MT) and Growth Rate Forecast
Figure Europe 2018-2025 Vaccine Adjuvants Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Vaccine Adjuvants Consumption Volume (MT) and Growth Rate Forecast
Figure Japan 2018-2025 Vaccine Adjuvants Consumption Volume (MT) and Growth Rate Forecast
Figure India 2018-2025 Vaccine Adjuvants Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Vaccine Adjuvants by Type 2018-2025
Table Global Consumption Volume (MT) of Vaccine Adjuvants by Application 2018-2025
Table Traders or Distributors with Contact Information of Vaccine Adjuvants by Region


More Publications